Technical

Stemedica Cell Technologies, Inc., a US company with investment from JZT, received US FDA approval of its application for a Phase II clinical trial treating COVID-19 patients with MSCs.


Stemedica Cell Technologies, Inc., a US company with investment from JZT, received US FDA approval of its application for a Phase II clinical trial treating COVID-19 patients with MSCs.